Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-015360

Chief Commercial Officer acquired 55,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Yarema Kristin Chief Commercial Officer 2020-03-01 Grant or award +55,000 55,000 D
Loading xslF345X03/doc4.xml…